WO2024026302A3 - Compositions and methods for adeno-associated viral production - Google Patents
Compositions and methods for adeno-associated viral production Download PDFInfo
- Publication number
- WO2024026302A3 WO2024026302A3 PCT/US2023/070927 US2023070927W WO2024026302A3 WO 2024026302 A3 WO2024026302 A3 WO 2024026302A3 US 2023070927 W US2023070927 W US 2023070927W WO 2024026302 A3 WO2024026302 A3 WO 2024026302A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- adeno
- compositions
- genetically engineered
- associated viral
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
- 108010091086 Recombinases Proteins 0.000 abstract 1
- 102000018120 Recombinases Human genes 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000002123 temporal effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10344—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/50—Vectors for producing vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Disclosed herein are cell genetically engineered cells for AAV production. The genetically engineered cells comprise molecular systems for temporal control of expression of genes required for AAV production. Also disclosed herein are methods of using genetically engineered cells for AAV production. Further, wherein the expression control component comprises a polynucleic acid molecule encoding for a recombinase.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263369476P | 2022-07-26 | 2022-07-26 | |
US63/369,476 | 2022-07-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2024026302A2 WO2024026302A2 (en) | 2024-02-01 |
WO2024026302A3 true WO2024026302A3 (en) | 2024-03-28 |
Family
ID=89707269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/070927 WO2024026302A2 (en) | 2022-07-26 | 2023-07-25 | Compositions and methods for adeno-associated viral production |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024026302A2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006020480A2 (en) * | 2004-08-09 | 2006-02-23 | Merck & Co., Inc. | Adenoviral vector compositions |
US20210348194A1 (en) * | 2018-10-05 | 2021-11-11 | Voyager Therapeutics, Inc. | Engineered nucleic acid constructs encoding aav production proteins |
WO2021226558A1 (en) * | 2020-05-08 | 2021-11-11 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
WO2022015788A1 (en) * | 2020-07-14 | 2022-01-20 | Abeona Therapeutics Inc. | Recombinant adeno-associated viral vectors for multipartite gene delivery |
US20220154223A1 (en) * | 2020-10-15 | 2022-05-19 | Hoffmann-La Roche Inc. | Nucleic acid constructs for simultaneous gene activation |
-
2023
- 2023-07-25 WO PCT/US2023/070927 patent/WO2024026302A2/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006020480A2 (en) * | 2004-08-09 | 2006-02-23 | Merck & Co., Inc. | Adenoviral vector compositions |
US20210348194A1 (en) * | 2018-10-05 | 2021-11-11 | Voyager Therapeutics, Inc. | Engineered nucleic acid constructs encoding aav production proteins |
WO2021226558A1 (en) * | 2020-05-08 | 2021-11-11 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
WO2022015788A1 (en) * | 2020-07-14 | 2022-01-20 | Abeona Therapeutics Inc. | Recombinant adeno-associated viral vectors for multipartite gene delivery |
US20220154223A1 (en) * | 2020-10-15 | 2022-05-19 | Hoffmann-La Roche Inc. | Nucleic acid constructs for simultaneous gene activation |
Non-Patent Citations (1)
Title |
---|
AU HAU KIU EDNA, ISALAN MARK, MIELCAREK MICHAL: "Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings", FRONTIERS IN MEDICINE, vol. 8, XP093044395, DOI: 10.3389/fmed.2021.809118 * |
Also Published As
Publication number | Publication date |
---|---|
WO2024026302A2 (en) | 2024-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2061891A4 (en) | Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor | |
EP2110875A4 (en) | Polymer electrolyte membrane, method for producing the same, membrane-electrode assembly and solid polymer fuel cell | |
Sergeeva et al. | Multicopy targeted integration for accelerated development of high-producing Chinese hamster ovary cells | |
WO2008021140A3 (en) | Recombinant aav production in mammalian cells | |
WO2020127417A3 (en) | PRODUCTION OF 3-FUCOSYLLACTOSE AND LACTOSE CONVERTING α-1,3-FUCOSYLTRANSFERASE ENZYMES | |
HK1046926A1 (en) | Methods and compositions for directed cloning and subcloning using homologous recombination. | |
WO2006012414A3 (en) | Novel polyadenylation signal for use in expression vectors | |
WO2012172277A4 (en) | Simian adenovirus and hybrid adenoviral vectors | |
JP2011504721A5 (en) | ||
WO2005001037A3 (en) | Electrolyte membranes based on alkyloxysilane grafted thermoplastic polymers | |
IN2005MU00356A (en) | ||
WO2024026302A3 (en) | Compositions and methods for adeno-associated viral production | |
JP4685037B2 (en) | Polymer, cross-linked polymer, composition for polymer solid electrolyte, polymer solid electrolyte, and adhesive composition | |
BR112021026326A2 (en) | Engineered sucrose phosphorylase, composition, polynucleotide sequence, expression vector, host cell, and method for producing an engineered sucrose phosphorylase | |
WO2004027048A3 (en) | High titer recombinant aav production | |
WO2021016227A8 (en) | Synthetic genetic elements for biomanufacture | |
CN112029699A (en) | Clostridium butyricum gene editing system based on endogenous CRISPR-Cas system and application thereof | |
WO2022236080A3 (en) | Compositions and methods for adeno-associated viral production | |
EP1918330A4 (en) | Ion-conductive material, solid polymer electrolyte membrane, and fuel battery | |
AU2003233855A1 (en) | Low-viscosity polyisocyanate composition having high functionality and method for preparing same | |
WO2021231488A3 (en) | D-allulose 3-epimerases for bioconversion of d-fructose to d-allulose | |
MX2022013477A (en) | Miniaturized dystrophins having spectrin fusion domains and uses thereof. | |
WO2021195491A3 (en) | Inducible promoter for viral vector production | |
WO2021231263A3 (en) | Nucleic acid amplification methods | |
BR112021024819A2 (en) | Engineered acetate kinase, composition, polynucleotide sequence, expression vector, host cell, and production method of an engineered acetate kinase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23847502 Country of ref document: EP Kind code of ref document: A2 |